Guardant Health to Participate in Upcoming June Investor Conferences
26 Maio 2023 - 9:00AM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will be participating in the
following investor conferences.
- William Blair 43rd Annual Growth Stock Conference in Chicago,
IL Presentation on Tuesday, June 6th at 4:40 p.m. Central Time
- Goldman Sachs 44th Annual Global Healthcare Conference in Dana
Point, CA Fireside Chat on Monday, June 12th at 4:00 p.m. Pacific
Time
Interested parties may access live and archived webcasts of the
sessions on the “Investors” section of the company website at:
www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
tests, vast data sets and advanced analytics. The Guardant Health
oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched Guardant360®, Guardant360 CDx,
Guardant360 TissueNext™, Guardant360 Response™, and
GuardantINFINITY™ tests for advanced-stage cancer, and Guardant
Reveal™ for early-stage cancer. The Guardant Health screening
portfolio, including the commercially launched Shield™ test, aims
to address the needs of individuals eligible for cancer
screening.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230525005834/en/
Investor Contact: Alex Kleban
investors@guardanthealth.com +1 657-254-5417
Media Contact: Michael Weist press@guardanthealth.com +1
317-371-0035
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024